期刊文献+

激素补充治疗中不同雌激素的特点 被引量:22

The characteristics of different estrogens in hormone replacement treatment
原文传递
导出
摘要 雌激素是性激素补充治疗的核心。目前临床应用的雌激素种类繁多。本文以用药途径为主线,详细介绍不同雌激素的特点。临床上需个体化选择适宜药物。对于缓解潮热出汗症状、预防骨质疏松症而言,全身用药,包括各种口服雌激素和经皮雌激素,均可达到满意的疗效。对于有肝胆功能障碍或血栓形成高危因素者,经皮雌激素更有优势。对于仅存在阴道局部症状者,建议局部用药。建议使用最低有效剂量。 Estrogen is the core of hormone replacement therapy (HRT). Currently there are a wide variety of estrogens used in HRT. This article has detailed the characteristics of different estrogens according to administration route. Appropriate estrogen preparations should be chosen by individualized clinical needs. To alleviate the symptoms such as hot flushes and sweating,as well as to prevent osteoporosis, systemic administration can achieve satisfactory results including oral estrogen and transdermal estrogen. Transdermal estrogen has more advantages for patients with liver dysfunction or thrombosis risk factors. Local application with lowest effective dose of estrogen is recommended for those who only have vaginal symptoms.
作者 陈蓉 吴丽萍
出处 《中国计划生育和妇产科》 2012年第5期13-16,共4页 Chinese Journal of Family Planning & Gynecotokology
关键词 激素补充治疗 雌激素 用药途径 hormone replacement therapy estrogen administration route
  • 相关文献

参考文献14

二级参考文献22

  • 1Board of the International Menopause Society,Pines A,Sturdee DW,et al.IMS updated recommendations on postmenopausal hormone therapy.Climacteric,2007,10:181-194.
  • 2Gompel A,Rozenberg S,Barlow DH,et al.The EMAS 2008update on clinical recommendations on postmenopausal hormone replacement therapy.Maturitas,2008,61:227-232.
  • 3Utian WH,Archer DF,Bachmann GA,et al.Estrogen and progestogen use in postmenopausal women:July 2008 position statement of The North American Menopause Society.Menopause,2008,15:584-602.
  • 4North American Menopause Society.The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women:2007 position statement of The North American Menopause Society.Menopause,2007,14:355-369.
  • 5APMF 2008 Consensus Statement on the Management of the Menopause[DB/OL] .[2010-7-2] .http://www.apmf.net/news/.
  • 6MICROMEDEX(R)Healthcare Series,2010,Vol.146.Q4[DB/CD.].
  • 7Carlo Bulletti,Dominique de Ziegler,Carlo Flamigni,et al.Targeted drug delivery in gynaecology:the fire uterine pass effect[J].Human Reproduction,1997,2(5):1073-1079.
  • 8Speroff L.Efficacy and tolerability of a novel estrodiol vaginal ring for relief of menopausal symptoms[J].Obstet Gynecol,2003,102(4):823-834.
  • 9Buckler H,Al-Azzawi F,UK VR Multicentre Trial Group.The effect of a novel vaginal ring oestradiol acetate on climacteric symptoms in postmenopausal women[J].BJOG,2003,110(8):753-759.
  • 10Tourgeman DE,Gentzchein E,Stanczyk FZ,et al.Serum and tissue hormone levels of vaginally and orally administered estradiol[J].Am J Obstet Gynecol,1999,180(6 pt 1):1480-1483.

共引文献182

同被引文献205

引证文献22

二级引证文献197

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部